Contraceptive agents case studies

Ellery C, MacLennan R, Berry G, Shearman RP. A case-control study of breast cancer in relation to the use of steroid contraceptive agents. Med J Aust 1986 144(4) 173-6. 

Women who are taking or considering hormone replacement therapy should be informed of the potential increased risk of dry eye syndrome with this therapy. Women on oral contraceptives who complain of dry eye or in whom ocular surface disease is noted should be advised of the potential causative aspects of their medication. In either case, therapies for dry eye are usually based on topical administration of tear substitutes, lid treatments, environmental modification, and immunomodulatory agents for inflammatory-related ocular surfece disease. Hormone-based eyedrops are being studied with respect to targeting postmenopausal women with dry eye. 

---